$WAT
WATERS CORP /DE/

2023 Q1 Form 10-K Financial Statement

#000119312523050827 Filed on February 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q2
Revenue $684.7M $708.6M $690.6M
YoY Change -0.85% 7.48% 13.49%
Cost Of Revenue $284.4M $307.1M $285.7M
YoY Change -0.46% 13.27% 12.43%
Gross Profit $400.3M $401.5M $404.9M
YoY Change -1.13% 3.44% 14.25%
Gross Profit Margin 58.46% 56.66% 58.63%
Selling, General & Admin $182.0M $164.4M $157.5M
YoY Change 15.55% 7.78% 9.97%
% of Gross Profit 45.46% 40.96% 38.89%
Research & Development $42.69M $43.44M $50.27M
YoY Change 5.48% 3.45% 31.94%
% of Gross Profit 10.66% 10.82% 12.42%
Depreciation & Amortization $62.15M $32.66M
YoY Change 87.29% 4.36%
% of Gross Profit 15.48% 8.07%
Operating Expenses $224.6M $207.9M $209.4M
YoY Change 13.49% 5.89% 14.31%
Operating Profit $174.2M $192.0M $195.5M
YoY Change -10.9% 0.1% 14.18%
Interest Expense $14.44M $12.42M -$8.945M
YoY Change 30.61% -245.55% 31.54%
% of Operating Profit 8.29% 6.47% -4.58%
Other Income/Expense, Net $1.388M $895.0K $170.0K
YoY Change 716.47% -247.45% -98.19%
Pretax Income $165.2M $183.4M $186.7M
YoY Change -11.53% 0.39% 7.42%
Income Tax $24.25M $27.38M $26.86M
% Of Pretax Income 14.68% 14.93% 14.39%
Net Earnings $156.0M $159.8M
YoY Change -3.22% 7.92%
Net Earnings / Revenue 22.02% 23.14%
Basic Earnings Per Share $2.39 $2.61 $2.74
Diluted Earnings Per Share $2.38 $2.60 $2.622M
COMMON SHARES
Basic Shares Outstanding 58.94M 59.80M 60.21M
Diluted Shares Outstanding 59.32M 60.08M 60.51M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $444.5M $503.1M
YoY Change -32.16% -37.87%
Cash & Equivalents $443.6M $480.1M
Short-Term Investments $876.0K $23.03M
Other Short-Term Assets $87.91M $92.92M
YoY Change -3.3% 16.87%
Inventory $442.2M $381.9M
Prepaid Expenses
Receivables $600.9M $607.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.576B $1.585B
YoY Change -3.28% -10.34%
LONG-TERM ASSETS
Property, Plant & Equipment $547.4M $634.1M
YoY Change -0.1% 5.34%
Goodwill $420.0M
YoY Change -4.11%
Intangibles $213.4M
YoY Change -11.95%
Long-Term Investments
YoY Change
Other Assets $227.1M $149.7M
YoY Change 48.36% -7.91%
Total Long-Term Assets $1.494B $1.456B
YoY Change 1.94% 0.86%
TOTAL ASSETS
Total Short-Term Assets $1.576B $1.585B
Total Long-Term Assets $1.494B $1.456B
Total Assets $3.070B $3.041B
YoY Change -0.8% -5.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $96.57M $93.24M
YoY Change -0.24% 14.4%
Accrued Expenses $99.45M $70.07M
YoY Change -12.4% -3.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.545B
YoY Change
Total Short-Term Liabilities $732.0M $687.8M
YoY Change 7.56% -12.38%
LONG-TERM LIABILITIES
Long-Term Debt $1.495B $1.444B
YoY Change -1.27% -9.92%
Other Long-Term Liabilities $99.84M $214.5M
YoY Change 11.18% -8.57%
Total Long-Term Liabilities $1.953B $1.659B
YoY Change -4.59% -9.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $732.0M $687.8M
Total Long-Term Liabilities $1.953B $1.659B
Total Liabilities $2.685B $2.666B
YoY Change -1.56% -10.54%
SHAREHOLDERS EQUITY
Retained Earnings $8.282B
YoY Change 6.16%
Common Stock $2.183B
YoY Change 3.15%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.915B
YoY Change 5.06%
Treasury Stock Shares $102.8M
Shareholders Equity $385.2M $374.9M
YoY Change
Total Liabilities & Shareholders Equity $3.070B $3.041B
YoY Change -0.8% -5.3%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q2
OPERATING ACTIVITIES
Net Income $156.0M $159.8M
YoY Change -3.22% 7.92%
Depreciation, Depletion And Amortization $62.15M $32.66M
YoY Change 87.29% 4.36%
Cash From Operating Activities $158.1M $198.0M
YoY Change -5.84% -9.36%
INVESTING ACTIVITIES
Capital Expenditures -$41.63M -$32.65M
YoY Change 4.79% -17.35%
Acquisitions
YoY Change
Other Investing Activities $3.249M $51.64M
YoY Change -95.51% -143.21%
Cash From Investing Activities -$38.38M $18.99M
YoY Change -217.45% -111.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $70.00M
YoY Change
Cash From Financing Activities -88.01M -227.4M
YoY Change -35.15% -220.45%
NET CHANGE
Cash From Operating Activities 158.1M 198.0M
Cash From Investing Activities -38.38M 18.99M
Cash From Financing Activities -88.01M -227.4M
Net Change In Cash 31.70M -10.46M
YoY Change -51.12% -104.21%
FREE CASH FLOW
Cash From Operating Activities $158.1M $198.0M
Capital Expenditures -$41.63M -$32.65M
Free Cash Flow $199.7M $230.6M
YoY Change -3.8% -10.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
20209471189000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58943567
CY2022 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
CY2022 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
480529000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
501234000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
862000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
68051000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
722892000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
612648000
CY2022Q4 us-gaap Inventory Net
InventoryNet
455710000
CY2021Q4 us-gaap Inventory Net
InventoryNet
356095000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
103910000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
90914000
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001000697
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
01-14010
CY2022 dei Entity Registrant Name
EntityRegistrantName
Waters Corporation
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3668640
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
34 Maple Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Milford
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01757
CY2022 dei City Area Code
CityAreaCode
508
CY2022 dei Local Phone Number
LocalPhoneNumber
478-2000
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022 dei Trading Symbol
TradingSymbol
WAT
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1763903000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1628942000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
582217000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
547913000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
227399000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
242401000
CY2022Q4 us-gaap Goodwill
Goodwill
430328000
CY2021Q4 us-gaap Goodwill
Goodwill
437865000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
86506000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
84734000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
191100000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
153077000
CY2022Q4 us-gaap Assets
Assets
3281453000
CY2021Q4 us-gaap Assets
Assets
3094932000
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
50000000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
93302000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
96799000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103300000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
101192000
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
227908000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
227561000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26429000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27906000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
132545000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
61278000
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
11949000
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
10718000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
140304000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
155054000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
785737000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
680508000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1524878000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1513870000
CY2022Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
38203000
CY2021Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
64027000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
248496000
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
319547000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62108000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59623000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
117543000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
89803000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1991228000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2046870000
CY2022Q4 us-gaap Liabilities
Liabilities
2776965000
CY2021Q4 us-gaap Liabilities
Liabilities
2727378000
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162425000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162084000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59104000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60728000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1624000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1621000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2199824000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2114880000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8508587000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7800832000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
103321000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
101356000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10063975000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9437914000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-141572000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-111865000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
504488000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
367554000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3281453000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3094932000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2971956000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2785874000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2365365000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
658026000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
626968000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
553698000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
176190000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
168358000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
140777000
CY2022 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
6366000
CY2021 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
7143000
CY2020 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
10587000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
6945000
CY2022 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2021 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5165000
CY2020 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1180000
CY2022 wat Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
9797000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
2098561000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
1964167000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
1719876000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
873395000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
821707000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
645489000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2228000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17203000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1775000
CY2022 us-gaap Interest Expense
InterestExpense
48797000
CY2021 us-gaap Interest Expense
InterestExpense
44938000
CY2020 us-gaap Interest Expense
InterestExpense
49070000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
11020000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
12221000
CY2022 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-5119000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
16270000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
837846000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
806193000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
610914000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
130091000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113350000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
89343000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
707755000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
692843000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
521571000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.8
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.25
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.4
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59985000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61575000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62094000
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.73
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.17
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.36
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60331000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62028000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62414000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
707755000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
692843000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
521571000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-46135000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1903000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5984000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
26000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-26000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
0
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
6000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-6000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
20000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-20000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0
CY2022 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
-20953000
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
-9342000
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
6786000
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
574000
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
1167000
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
1389000
CY2022 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
-21527000
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
-10509000
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
5397000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4490000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
37865000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
60984000
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-2508000
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
941000
CY2022 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-16408000
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-8001000
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
4456000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29707000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6078000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1528000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
678048000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
698921000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
523099000
CY2022 us-gaap Profit Loss
ProfitLoss
707755000
CY2021 us-gaap Profit Loss
ProfitLoss
692843000
CY2020 us-gaap Profit Loss
ProfitLoss
521571000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
42564000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
29918000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
36865000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-31988000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
16633000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2693000
CY2022 us-gaap Depreciation
Depreciation
71998000
CY2021 us-gaap Depreciation
Depreciation
71560000
CY2020 us-gaap Depreciation
Depreciation
68685000
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
58425000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
60120000
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
56676000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
6945000
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
9707000
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
CY2022 wat Researchanddevelopmentinprocessandnoncashitems
Researchanddevelopmentinprocessandnoncashitems
10003000
CY2021 wat Researchanddevelopmentinprocessandnoncashitems
Researchanddevelopmentinprocessandnoncashitems
0
CY2020 wat Researchanddevelopmentinprocessandnoncashitems
Researchanddevelopmentinprocessandnoncashitems
0
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
137874000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
62448000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37467000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
101902000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
67250000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-18940000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
23074000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
20765000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
27030000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5514000
CY2022Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
25532000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
46110000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
140598000
CY2022 us-gaap Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination
12862000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-509633000
CY2021 us-gaap Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination
37845000
CY2020 us-gaap Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination
11073000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-52578000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-52075000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-40725000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
611661000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
747274000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
790507000
CY2022 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
175921000
CY2021 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
161266000
CY2020 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
172384000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
80545000
CY2022 wat Proceeds Payments Of Equity Investments
ProceedsPaymentsOfEquityInvestments
8903000
CY2021 wat Proceeds Payments Of Equity Investments
ProceedsPaymentsOfEquityInvestments
-1788000
CY2020 wat Proceeds Payments Of Equity Investments
ProceedsPaymentsOfEquityInvestments
-6143000
CY2022 wat Payments For Intellectual Property Licenses
PaymentsForIntellectualPropertyLicenses
7535000
CY2021 wat Payments For Intellectual Property Licenses
PaymentsForIntellectualPropertyLicenses
7000000
CY2020 wat Payments For Intellectual Property Licenses
PaymentsForIntellectualPropertyLicenses
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
11407000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
279660000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
25884000
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
77993000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
218084000
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
20862000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-107967000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-231630000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-264094000
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
205000000
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
510000000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
315000000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
145000000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
350000000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
640366000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8537000
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
42801000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
55643000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
66033000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
626061000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
648930000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
196409000
CY2022 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-13627000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-438275000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-440502000
CY2021 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-3549000
CY2020 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-15240000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
45788000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14766000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12830000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15069000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20705000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64539000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
100980000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
501234000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436695000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
335715000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
480529000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
501234000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436695000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
160082000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
153504000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
97621000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
48083000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
42408000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
52103000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-216281000
CY2020 wat Adoption Of New Accounting Pronouncement One
AdoptionOfNewAccountingPronouncementOne
-985000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
521571000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1528000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7531000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
58502000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
176408000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
36686000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
232144000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
692843000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6078000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9578000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
46065000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
648930000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29776000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
367554000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
707755000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-29707000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
10952000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31678000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
626061000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
42317000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
504488000
CY2022Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
1509000
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6390000
CY2021Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
38729000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
111301000
CY2021Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
1347000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities at the dates of the financial statements. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, goodwill and intangible assets, income taxes, litigation and inventory valuation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual amounts may differ from these estimates under different assumptions or conditions. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-31000000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5000000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7000000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6905000
CY2022 us-gaap Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
Cash equivalents represent highly liquid investments, with original maturities of 90 days or less, primarily in bank deposits, U.S. treasury bill money market funds and commercial paper.
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
481000000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
569000000
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
481000000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
569000000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13228000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-6509000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5426000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14311000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14381000
CY2021 us-gaap Accounts Receivable Change In Method Credit Loss Expense Reversal
AccountsReceivableChangeInMethodCreditLossExpenseReversal
0
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-5380000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6533000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13228000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9560000
CY2020 us-gaap Accounts Receivable Change In Method Credit Loss Expense Reversal
AccountsReceivableChangeInMethodCreditLossExpenseReversal
985000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-9051000
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5215000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14381000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div><br/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">The Company sells its products and services to a significant number of large and small customers throughout the world, with net sales to the pharmaceutical industry of approximately 59%, 60% and 59% in 2022, 2021 and 2020, respectively. None of the Company’s individual customers accounted for more than 2% of annual Company sales in 2022, 2021 or 2020. The Company performs continuing credit evaluations of its customers and generally does not require collateral, but in certain circumstances may require letters of credit or deposits. Historically, the Company has not <div style="letter-spacing: 0px; top: 0px;;display:inline;">experienced significant credit losses. </div> </div></div>
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
7000000
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
46000000
CY2021 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
36000000
CY2020 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
53000000
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
148000000
CY2021Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
155000000
CY2022 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
10000000
CY2022 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
1000000
CY2021 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
2000000
CY2020 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
6000000
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
10000000
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
8836000
CY2022 us-gaap Description Of Foreign Currency Exposure
DescriptionOfForeignCurrencyExposure
The Company is a global company that operates in over 35 countries and, as a result, the Company’s net sales, cost of sales, operating expenses and balance sheet amounts are significantly impacted by fluctuations in foreign currency exchange rates.
CY2022 us-gaap Description Of Foreign Currency Derivative Activities
DescriptionOfForeignCurrencyDerivativeActivities
The Company periodically aggregates its net worldwide balances by currency and then enters into foreign currency exchange contracts that mature within 90 days to hedge a portion of the remaining balance to minimize some of the Company’s currency price risk exposure. The foreign currency exchange contracts are not designated for hedge accounting treatment.
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
10718000
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
10067000
CY2022 us-gaap Property Plant And Equipment Income Statement Disclosures
PropertyPlantAndEquipmentIncomeStatementDisclosures
Gains or losses on disposals were immaterial for the years ended December 31, 2022, 2021 and 2020.
CY2022Q4 us-gaap Goodwill
Goodwill
430000000
CY2021Q4 us-gaap Goodwill
Goodwill
438000000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
8000000
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
11949000
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
10950000
CY2021 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
8799000
CY2021 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
9031000
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
10718000
CY2019Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
11964000
CY2020 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
7909000
CY2020 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
8923000
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
10950000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
7000000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
7000000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
6000000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
915298000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
687899000
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P7Y
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
273598000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
239759000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
213695000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
230615000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
216920000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
198209000
CY2022 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
242192000
CY2021 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
250759000
CY2020 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
224273000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
285175000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
273598000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
239759000
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
901628000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
659227000
CY2021 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P7Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
227908000
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
34018000
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P25M
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23249000
CY2022Q4 wat Revenue Remaining Performance Obligation Current And Noncurrent
RevenueRemainingPerformanceObligationCurrentAndNoncurrent
285175000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
862000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
862000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
862000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
862000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
72094000
CY2021Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2021Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
26000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
72068000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
72094000
CY2021Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2021Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
26000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
72068000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
862000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
71066000
CY2021Q4 wat Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
1002000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
862000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
72068000
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
54000000
CY2020 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
19000000
CY2021 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
55000000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
205760000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
165240000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19899000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19726000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
230051000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
171129000
CY2022Q4 us-gaap Inventory Net
InventoryNet
455710000
CY2021Q4 us-gaap Inventory Net
InventoryNet
356095000
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
14000000
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
9000000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
12000000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1284339000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1221429000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
702122000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
673516000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
582217000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
547913000
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
24000000
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
23000000
CY2020 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
68000000
CY2022 wat Intangible Assets Gross Foreign Currency Translation Adjustments
IntangibleAssetsGrossForeignCurrencyTranslationAdjustments
-40000000
CY2022 wat Intangible Assets Accumulated Amortization Foreign Currency Translation Adjustments
IntangibleAssetsAccumulatedAmortizationForeignCurrencyTranslationAdjustments
-29000000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58000000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
60000000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
57000000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
61000000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
61000000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
61000000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
61000000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
61000000
CY2022 us-gaap Debt Instrument Fee
DebtInstrumentFee
The interest rates applicable to the 2021 Credit Agreement are, at the Company’s option, equal to either the alternate base rate (which is a rate per annum equal to the greatest of (1) the prime rate in effect on such day, (2) the Federal Reserve Bank of New York Rate on such day plus 1/2 of 1% per annum and (3) the adjusted LIBO rate on such day (or if such day is not a business day, the immediately preceding business day) for a deposit in U.S. dollars with a maturity of one month plus 1% per annum) or the applicable 1, 3 or 6 month adjusted LIBO rate or EURIBO rate for euro-denominated loans, in each case, plus an interest rate margin based upon the Company’s leverage ratio, which can range between 0 and 12.5 basis points for alternate base rate loans and between 80 and 112.5 basis points for LIBO rate or EURIBO rate loans. The facility fee on the 2021 Credit Agreement ranges between 7.5 and 25 basis points per annum, based on the leverage ratio, of the amount of the revolving facility commitments and the outstanding term loan.
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
50000000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5122000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6130000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1524878000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1513870000
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1574878000
CY2021Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1513870000
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
113000000
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
121000000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
50000000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
100000000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
730000000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
700000000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1580000000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1017000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
133816000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
144410000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
75193000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
704030000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
661783000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
535721000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
837846000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
806193000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
610914000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
62153000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
16302000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
28385000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8025000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3691000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4243000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
91901000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
76724000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
59408000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
162079000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
96717000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
92036000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-26551000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
10491000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-8244000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-4420000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
345000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-506000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
5797000
CY2021 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.32
CY2020 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.33
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
6057000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-31988000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
16633000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2693000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
130091000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113350000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
89343000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
175948000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
169300000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
128292000
CY2022 wat Incometax Rate Reconciliation Global Intangible Low Taxed Income
IncometaxRateReconciliationGlobalIntangibleLowTaxedIncome
17812000
CY2021 wat Incometax Rate Reconciliation Global Intangible Low Taxed Income
IncometaxRateReconciliationGlobalIntangibleLowTaxedIncome
10476000
CY2020 wat Incometax Rate Reconciliation Global Intangible Low Taxed Income
IncometaxRateReconciliationGlobalIntangibleLowTaxedIncome
13319000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3605000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4036000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2415000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-54549000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-54566000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-48962000
CY2022 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
7341000
CY2021 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
6682000
CY2020 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
6798000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-5384000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-9214000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1077000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
130091000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113350000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
89343000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.155
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.141
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.146
CY2022 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
20000000
CY2021 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
20000000
CY2020 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
21000000
CY2022 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.33
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
18677000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
4000000
CY2021 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
4000000
CY2020 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
3000000
CY2022Q4 wat Deferred Tax Assets Net Operating Loss Carry Forwards And Credits
DeferredTaxAssetsNetOperatingLossCarryForwardsAndCredits
51945000
CY2021Q4 wat Deferred Tax Assets Net Operating Loss Carry Forwards And Credits
DeferredTaxAssetsNetOperatingLossCarryForwardsAndCredits
55813000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
18000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0
CY2022Q4 wat Deferred Tax Assets Operating Lease Assets
DeferredTaxAssetsOperatingLeaseAssets
19771000
CY2021Q4 wat Deferred Tax Assets Operating Lease Assets
DeferredTaxAssetsOperatingLeaseAssets
19288000
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2713000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2316000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7947000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8074000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
23488000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
30105000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
13555000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10997000
CY2022Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
23000
CY2021Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
3083000
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
6463000
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
5405000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
4815000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
6675000
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
1858000
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
2266000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
34234000
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1098000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6713000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
167928000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
150735000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
54300000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
58834000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
113628000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
91901000
CY2022Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
25429000
CY2021Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
24357000
CY2022Q4 wat Deferred Tax Liabilities Operating Lease Assets
DeferredTaxLiabilitiesOperatingLeaseAssets
19543000
CY2021Q4 wat Deferred Tax Liabilities Operating Lease Assets
DeferredTaxLiabilitiesOperatingLeaseAssets
19251000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
16057000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
15534000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3481000
CY2021Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
17283000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
79706000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
79906000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
23000000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
33922000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11995000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
54000000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
28692000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
28666000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
27790000
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
1300000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
399000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
818000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
433000
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
684000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1145000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1759000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1959000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
29019000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
28692000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
28666000
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
29000000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
58834000
CY2022 wat Valuation Allowance Deferred Tax Asset Charged To Income Tax Provision
ValuationAllowanceDeferredTaxAssetChargedToIncomeTaxProvision
-1647000
CY2022 wat Valuation Allowance Deferred Tax Asset Change Others
ValuationAllowanceDeferredTaxAssetChangeOthers
-2887000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
54300000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60101000
CY2021 wat Valuation Allowance Deferred Tax Asset Charged To Income Tax Provision
ValuationAllowanceDeferredTaxAssetChargedToIncomeTaxProvision
2919000
CY2021 wat Valuation Allowance Deferred Tax Asset Change Others
ValuationAllowanceDeferredTaxAssetChangeOthers
-4186000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
58834000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
51221000
CY2020 wat Valuation Allowance Deferred Tax Asset Charged To Income Tax Provision
ValuationAllowanceDeferredTaxAssetChargedToIncomeTaxProvision
1137000
CY2020 wat Valuation Allowance Deferred Tax Asset Change Others
ValuationAllowanceDeferredTaxAssetChangeOthers
7743000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60101000
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
300000
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
300000
CY2021 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
5000000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y4M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
36000000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
34000000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
38000000
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0324
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0304
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
36000000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
34000000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
38000000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12000000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3000000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16000000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
86506000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
84734000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26429000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27906000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62108000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59623000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
88537000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
87529000
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
500000
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
188.21
CY2021Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
162.09
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
154.16
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
39000000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
600000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
62000000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
28494000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
23472000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
14121000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12933000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6970000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
8921000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
94911000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6374000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
88537000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26429000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62108000
CY2022 wat Future Minimum License Fees Payable
FutureMinimumLicenseFeesPayable
Future minimum license fees payable under existing license agreements as of December 31, 2022 are immaterial for the years ended December 31, 2022 and thereafter.
CY2022Q4 wat Potentials Payments Under Licensing Arrangements
PotentialsPaymentsUnderLicensingArrangements
2000000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6500000
CY2022 wat Employee Stock Purchase Plan Maximum Contribution Allowed As Percent Of Employees Earnings
EmployeeStockPurchasePlanMaximumContributionAllowedAsPercentOfEmployeesEarnings
0.15
CY2022Q4 wat Employee Stock Purchase Plan Total Number Of Shares Purchased
EmployeeStockPurchasePlanTotalNumberOfSharesPurchased
1600000
CY2022 wat Employee Stock Purchase Plan Period In Months
EmployeeStockPurchasePlanPeriodInMonths
P3M
CY2022 wat Employee Stock Purchase Plan Purchase Price Calculation For Shares Of Stock
EmployeeStockPurchasePlanPurchasePriceCalculationForSharesOfStock
The purchase price for each share of stock is the lesser of 90% of the market price on the first day of the plan period or 100% of the market price on the last day of the plan period.
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
237.99
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y8M12D
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42564000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29918000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36865000
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
597000
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
238.43
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
250000
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
188.21
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
31000000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
43000000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
45000000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
32000000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
46000000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
59000000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
62000000
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
320000
CY2020 wat Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.04
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
707755000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59985000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.8
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
346000
CY2022 wat Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.07
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
707755000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60331000
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.73
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
692843000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61575000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.25
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
453000
CY2021 wat Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.08
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
692843000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62028000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.17
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
521571000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62094000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.4
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
521571000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62414000
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.36
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
272000
CY2022 wat Retirement Plans Company Contributions To Other Non Us Retirement Plans
RetirementPlansCompanyContributionsToOtherNonUSRetirementPlans
16000000
CY2021 wat Retirement Plans Company Contributions To Other Non Us Retirement Plans
RetirementPlansCompanyContributionsToOtherNonUSRetirementPlans
17000000
CY2020 wat Retirement Plans Company Contributions To Other Non Us Retirement Plans
RetirementPlansCompanyContributionsToOtherNonUSRetirementPlans
14000000
CY2022 us-gaap Defined Benefit Plan Alternative Method Used To Amortize Net Gains And Losses
DefinedBenefitPlanAlternativeMethodUsedToAmortizeNetGainsAndLosses
amortize cumulative actuarial gains and losses in excess of 10% of the larger of the market-related value of plan assets and the projected benefit obligation over the expected future service of active participants.
CY2022 wat Defined Benefit Plan Effect Of One Quarter Percentage Point Increase In Return On Assets On Net Periodic Benefit Cost
DefinedBenefitPlanEffectOfOneQuarterPercentagePointIncreaseInReturnOnAssetsOnNetPeriodicBenefitCost
less than $1 million
CY2022 wat Defined Benefit Plan Effect Of One Quarter Percentage Point Increase In Discount Rate On Net Periodic Benefit Cost
DefinedBenefitPlanEffectOfOneQuarterPercentagePointIncreaseInDiscountRateOnNetPeriodicBenefitCost
less than $1 million
CY2022Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
5159000
CY2022Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
4268000
CY2022Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
4428000
CY2022Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
5040000
CY2022Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
6146000
CY2022Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
34573000
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2971956000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2785874000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2365365000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
195470000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2971956000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2785874000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2365365000
CY2022 wat Maximum Percentage Of Net Sales To Individual Customer
MaximumPercentageOfNetSalesToIndividualCustomer
0.02
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2971956000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2785874000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2365365000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
582217000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
547913000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
494003000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
690572000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
714319000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
708555000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
858510000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2971956000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
285685000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
307206000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
307101000
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
348190000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1248182000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
157475000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
161877000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
164417000
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
174257000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
658026000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40472000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44006000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43435000
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48277000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
176190000
CY2022Q1 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1673000
CY2022Q2 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1598000
CY2022Q3 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1592000
CY2022Q4 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1503000
CY2022 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
6366000
CY2022Q1 wat Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
9797000
CY2022 wat Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
9797000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
495102000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
514687000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
516545000
CY2022Q4 us-gaap Costs And Expenses
CostsAndExpenses
572227000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
2098561000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.6
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
199632000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
192010000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
286283000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
873395000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
170000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1535000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
895000
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-372000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2228000
CY2022Q1 us-gaap Interest Expense
InterestExpense
11059000
CY2022Q2 us-gaap Interest Expense
InterestExpense
11419000
CY2022Q3 us-gaap Interest Expense
InterestExpense
12420000
CY2022Q4 us-gaap Interest Expense
InterestExpense
13899000
CY2022 us-gaap Interest Expense
InterestExpense
48797000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2114000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2526000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2896000
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
3484000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
11020000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
186695000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
192274000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
183381000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
275496000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
837846000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26864000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27410000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27383000
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48434000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
130091000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
159831000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
164864000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
155998000
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
227062000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
707755000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.64
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.74
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.61
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.83
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.8
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60580000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60206000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59801000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59329000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59985000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.62
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.72
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.81
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.73
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60952000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60510000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60081000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59644000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60331000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
608545000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
681647000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
659233000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
836449000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2785874000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
254147000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
280254000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
271128000
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
351004000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1156533000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
143196000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
158213000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
152545000
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
173014000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
626968000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38092000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44949000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41986000
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43331000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
168358000
CY2021Q1 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1840000
CY2021Q2 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1809000
CY2021Q3 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1759000
CY2021Q4 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1735000
CY2021 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
7143000
CY2021Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2021Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2021Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5165000
CY2021 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5165000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
437275000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
485225000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
467418000
CY2021Q4 us-gaap Costs And Expenses
CostsAndExpenses
574249000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
1964167000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
171270000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
196422000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
191815000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
262200000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
821707000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9359000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9321000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-607000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62028000
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
10000000
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-870000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17203000
CY2021Q1 us-gaap Interest Expense
InterestExpense
10946000
CY2021Q2 us-gaap Interest Expense
InterestExpense
12027000
CY2021Q3 us-gaap Interest Expense
InterestExpense
11081000
CY2021Q4 us-gaap Interest Expense
InterestExpense
10884000
CY2021 us-gaap Interest Expense
InterestExpense
44938000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
4101000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3698000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2548000
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1874000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
12221000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
173784000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
197414000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
182675000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
252320000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
806193000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25657000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30122000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21490000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36081000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113350000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
148127000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
167292000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
161185000
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
216239000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
692843000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.38
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.71
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.63
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.55
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.25
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62260000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61685000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61359000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60984000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61575000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.37
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.69
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.6
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.52
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.17
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62632000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62157000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61888000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61423000
CY2022 dei Auditor Firm
AuditorFirmId
238

Files In Submission

Name View Source Status
0001193125-23-050827-index-headers.html Edgar Link pending
0001193125-23-050827-index.html Edgar Link pending
0001193125-23-050827.txt Edgar Link pending
0001193125-23-050827-xbrl.zip Edgar Link pending
d412746d10k.htm Edgar Link pending
d412746dex211.htm Edgar Link pending
d412746dex231.htm Edgar Link pending
d412746dex311.htm Edgar Link pending
d412746dex312.htm Edgar Link pending
d412746dex321.htm Edgar Link pending
d412746dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g412746g60m30.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d412746d10k_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wat-20221231.xsd Edgar Link pending
wat-20221231_cal.xml Edgar Link unprocessable
wat-20221231_def.xml Edgar Link unprocessable
wat-20221231_lab.xml Edgar Link unprocessable
wat-20221231_pre.xml Edgar Link unprocessable